CreaGen Inc. is a US based premier Medicinal Chemistry/Drug Discovery and Contract Research Organization with 16 years of experience in collaborating with more than 50 biotech and pharmaceutical companies and a number of Federal agencies. Our core expertise is in synthesis of new chemical entities, preclinical drug discovery research, scale-up synthesis and early stage process development. From the earliest stages of drug discovery through IND enabling studies, CreaGen has the technical ability to accommodate a range of needs in the areas of drug discovery, drug product development and small and large-scale API synthesis. In addition CreaGen possesses exceptional expertise in non-conventional synthetic modalities such as nucleoside and antibody linker chemistry.

CreaGen’s goal is enable break-through research and empower pharmaceutical and biotech companies, academic institutions and federal research labs to advance the cutting edge of the pharmaceutical landscape.